Loading data
RARENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 673 m USD | 560 m USD | 434 m USD | 363.33 m USD | 351.41 m USD |
| Research and development expense | 750 m USD | 698 m USD | 648 m USD | 705.79 m USD | 497.15 m USD |
| Selling, general and administrative expense | 349 m USD | 321 m USD | 310 m USD | 278.14 m USD | 219.98 m USD |
| Operating profit | -535 m USD | -536 m USD | -569 m USD | -648.92 m USD | -381.74 m USD |
| Profit before tax | -571 m USD | -567 m USD | -609 m USD | -701.73 m USD | -452.98 m USD |
| Income tax expense | 4 m USD | 2 m USD | -2 m USD | 5.7 m USD | 1.04 m USD |
| Net income (reported basis) | -575.25 m USD | -569.18 m USD | -606.64 m USD | -707.42 m USD | -454.03 m USD |
| Basic earnings per share | -5.83 USD/share | -6.29 USD/share | -8.25 USD/share | -10.12 USD/share | -6.7 USD/share |
| Diluted earnings per share | -5.83 USD/share | -6.29 USD/share | -8.25 USD/share | -10.12 USD/share | -6.7 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.